DoW Breast Cancer, Era of Hope Scholar Award | HT942526BCRPEOHS

FY26 BCRP Era of Hope Scholar Award (HT942526BCRPEOHS) - FAQs

What is the FY26 Breast Cancer Research Program (BCRP) Era of Hope Scholar Award?

The FY26 BCRP Era of Hope Scholar Award is a U.S. Department of the Army (USAMRAA) discretionary grant opportunity that supports early-career investigators who show unusual promise to make a major, lasting impact in breast cancer research. The program is framed as an investment in people rather than a narrow investment in a single project.

Who is this award designed to support?

This award targets early-career investigators described as "the best and the brightest" in their fields, with clear indicators of high potential for leadership and influence in the breast cancer research community.

Is this grant more focused on the person or the project?

Based on the opportunity description, the award is intentionally focused on the Principal Investigator (PI) as a scholar and future leader, not just a single, narrowly defined project. Applications are expected to show the PI's promise, creativity, and likelihood of delivering innovative contributions toward ending breast cancer.

What kind of research approach is the program looking for?

The opportunity emphasizes creative and unconventional thinking, and it expects the PI's future work to be innovative and meaningful. The research direction can be ambitious and distinctive, as long as it remains aligned with program expectations described in the announcement.

Does the proposed work need to align with specific FY26 BCRP priorities?

Yes. Applications are expected to connect to the FY26 BCRP overarching challenges, or provide a strong justification for why an exception is appropriate.

Are collaborations and partnerships expected?

Yes. In addition to scientific excellence, the program places value on the PI's ability to build effective partnerships and collaborations. The description signals an expectation that scholars will work across disciplines and stakeholder groups rather than operating in isolation.

What is the minimum time commitment required for the PI?

The PI must commit at least 25% level of time and effort during the award period to conducting breast cancer research supported by this funding. This requirement underscores that the award is intended to be a substantial professional focus.

Are consumer advocates required to be part of the research team?

Yes. The research team must include at least two breast cancer consumer advocates. This reflects the program's emphasis on patient-centered perspectives and meaningful engagement with the community affected by breast cancer.

How many consumer advocates are required at minimum?

A minimum of two breast cancer consumer advocates must be included on the research team.

What is the Funding Opportunity Number for this grant?

The Funding Opportunity Number is HT942526BCRPEOHS.

What federal program listing (CFDA) is associated with this opportunity?

The opportunity is listed under CFDA 12.420.

What type of grant mechanism is this?

This is described as a discretionary grant opportunity.

What category does this opportunity fall under?

The listing places it in the science and technology/research and development category.

Who is eligible to apply?

Eligibility is listed as unrestricted, suggesting that a broad range of applicant organizations or institutions may apply, as long as they meet standard federal and program requirements.

When is the application deadline?

The application deadline shown in the listing is July 8, 2026.

How many awards are expected to be made?

The posting anticipates making a single award.

What is the maximum award amount (award ceiling)?

The award ceiling is not specified in the provided listing. Applicants would need to consult the full announcement or program guidance for budget limits and related constraints.

What is the long-term goal emphasized by the program?

The opportunity frames its long-term goal as ending breast cancer, and it expects funded scholars to make innovative and meaningful contributions toward that outcome.

What should an application emphasize based on the listing?

Based on the information provided, an application should emphasize the PI's track record of creative, unconventional thinking; indicators of leadership potential; plans for impactful breast cancer research; the ability to collaborate effectively; alignment with FY26 BCRP overarching challenges (or a strong justification for an exception); a PI commitment of at least 25% effort; and inclusion of at least two breast cancer consumer advocates on the team.